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Objective: Heart failure is a leading cause of death worldwide and in India, yet the qualitative data
regarding heart failure care are limited. To fill this gap, we studied the facilitators and barriers of heart
failure care in Kerala, India.
Methods and results: During January 2018, we conducted a qualitative study using in-depth, semi-
structured interviews with 21 health-care providers and quality administrators from 8 hospitals in Kerala
to understand the context, facilitators, and barriers of heart failure care. We developed a theoretical
framework using iteratively developed codes from these data to identify 6 key themes of heart failure
care in Kerala: (1) need for comprehensive patient and family education on heart failure; (2) gaps be-
tween guideline-directed clinical care for heart failure and clinical practice; (3) national hospital
accreditation contributing to a culture of systematically improving quality and safety of in-hospital care;
(4) limited system-level attention toward improving heart failure care compared with other cardiovas-
cular conditions; (5) application of existing personnel and technology to improve heart failure care; and
(6) longitudinal and recurrent costs as barriers for optimal heart failure care.
Conclusions: Key themes emerged regarding heart failure care in Kerala in the context of a health system
that is increasingly emphasizing health-care quality and safety. Targeted in-hospital quality improve-
ment interventions for heart failure should account for these themes to improve cardiovascular out-
comes in the region.
© 2019 Cardiological Society of India. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Heart failure is a leading cause of mortality and morbidity in
India.1 The incidence of heart failure is increasing, and the preva-
lence has been estimated to range from 1.3 to 4.6 million people in
India.2 The TrivandrumHeart Failure Registry (n¼ 1205) in Kerala, a
state with an estimated population of 34.8 million and a high
sociodemographic index, demonstrated the 3-year mortality rate of
patients hospitalized for heart failure was 45%.3 Only one of every
four (25%) patients with heart failurewith reduced ejection fractionartment of Medicine, North-
ago, IL, 60611 USA.
u (A. Agarwal).
blished by Elsevier B.V. This is anwas discharged from their index hospitalization on guideline-
directed medical therapy, including beta-blockers, angiotensin-
converting enzyme inhibitors or angiotensin receptor blockers, and
mineralocorticoid receptor antagonists. Patients discharged on
guideline-directed medical therapy had an 18% lower risk of death
at 3 years compared with those who were not discharged on these
medications, which highlights the potential gains if discharge
medication rates were increased in this population.3
A 2018 systematic review demonstrated poor quality of health
care has become a larger driver of mortality than low access to
care.4 The 2018 National Academy of Medicine report, “Crossing the
Global Quality Chasm: Improving Health Care Worldwide”, high-
lighted the urgency for comprehensive efforts to close such gaps in
health-care quality around the world, including in middle-incomeopen access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
In-depth interview participant characteristics.
Participant characteristic N (%)
Total participants 21
Type of heart failure provider
Cardiologist 9 (42.9)
Internal medicine physician 2 (9.5)
Cardiac care unit nurse 6 (28.6)
Quality administrator 4 (19.0)
Male 13 (61.9)
Employed by private hospital 18 (85.7)
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valued in cardiovascular health outcomes research for their ability
to describe complex phenomena in their natural settings.6,7
Furthermore, a deeper understanding of the context of care eluci-
dated by qualitative research methods is essential for improving
health-care quality. Given the burden of disease and potential gains
in improving the quality of heart failure care in India, we use
qualitative research methods to describe facilitators and barriers of
heart failure care in Kerala.
2. Methods
2.1. Study design
During January 2018, we conducted a qualitative study on acute
heart failure care, including the evaluation and management of
both heart failure with preserved ejection fraction and heart failure
with reduced ejection fraction, based on semi-structured in-
terviews with clinical and administrative staff at 8 hospital sites in
Kerala. A qualitative approach was selected to capture key aspects
of multifaceted heart failure care at the patient, family, provider,
health system, and health policy levels in a setting with limited
prior cardiovascular qualitative research using the socioecological
model.8,9 Furthermore, qualitative research is useful for generating
hypotheses and designing interventions that can be tested in future
quantitative or interventional research.10
We used a purposive sampling frame to select an initial sample
of participants who had diverse roles and experiences in the care of
patients with acute heart failure ranging from cardiologists to
cardiac care unit nurses to health-care quality administrators. We
then used a snowballing sampling technique based on the in-depth
interviews to recruit additional participants with increasing vari-
ability until we achieved theoretical saturation at which point no
novel concepts seemed to emerge.10 Participants were selected
from the 8 hospitals participating in the Heart Failure Quality
Improvement in Kerala study, which evaluated the effect of a
quality improvement toolkit on in-hospital care of patients with
heart failure using an interrupted time series design. Respondents
were invited to participate in person. The study was approved by
the Health Ministry Screening Committee of the Indian Council of
Medical Research (New Delhi, India), Ethics Committee of the
Centre for Chronic Disease Control (New Delhi, India), and Insti-
tutional Review Board at Duke University (Durham, USA).
2.2. Data collection and analysis
We conducted semi-structured interviews in person during
January 2018 using an adapted interview guide from prior research
in Kerala.9 Two members of the study team (A.A. and D.D.) con-
ducted the interviews except one interview, which was conducted
by one team member (D.D.) In-depth interviews began with open-
ended questions, and probes were used to elucidate emerging
themes. An iterative approach was used for data collection and
analysis based on the framework method for qualitative research.11
Interviews ranged from less than tenminutes to one hour in length.
All interviews were conducted in English, audiotaped, and subse-
quently transcribed verbatim.
The transcribed interviews were read multiple times for famil-
iarization. Codes were developed iteratively using an inductive
process by one author (A.A.) with input from coauthors (D.D., S.G.,
D.P., M.D.H., P.P.M.) andwere applied to specific excerpts in the text.
Codes were grouped into categories to develop a theoretical
framework to describe the key themes of heart failure care in Kerala
in the context of the socioecological model. We used Dedoose
v8.0.42 software (Manhattan Beach, USA) for data analysis andadhered to Consolidated Criteria for Reporting Qualitative Research
standards.123. Results
3.1. Participant characteristics
Our sample included 21 health-care providers and quality ad-
ministrators from 8 hospitals (Table 1). Most were cardiologists
(43%) and male (62%). Four (19%) participants were quality ad-
ministrators who were responsible for improving in-hospital
quality of care and safety by liaising with the National Accredita-
tion Board for Hospitals and Healthcare Providers.13 Most partici-
pants (86%) were employed by a private hospital. In addition to the
major themes described in the following section, we summarized
the primary facilitators and barriers of heart failure care in Kerala as
characterized by the participants (Table 2, Table 3).3.2. Study themes
3.2.1. Theme 1. There is need for comprehensive patient and family
education on heart failure, especially at the time of hospital
discharge
Participants identified discharge counseling as an area of
improvement.
“Discharge counselling is the main problem, because we have staff
shortage, that's why main problem is discharge counseling.”
(Nurse, private hospital)
“I think the area where we are probably lacking is we are not
spending time with the patient at the time of discharge. We are
spending [a] lot of time when they are coming back to OPD
[outpatient department]. At the time of discharge, they are in a
hurry to go, the vehicle is waiting, the discharge summary has to be
made ready. There is always a hurry.” (Cardiologist, private
hospital)
Participants identified patient and family education as a tool to
increase medication adherence, despite limited empirical data
supporting education alone for improving medication adherence
compared with health system arrangements for longitudinal care.14
Respondents specifically identified involvement of family members
as critical in the counseling process.
“The counseling part should be done along with family members
who will be with the patients most of the time at home. Like (the)
wife most of the cases, or if wife is not there, then children. They
should be with the patient at the time of counseling… involvement
of family is very important.” (Internal medicine physician, private
hospital)
Table 2
Barriers of heart failure care in Kerala, India.
Health system level
 Focus on acute coronary syndrome with established systems of care and subsequently limited emphasis on heart failure
 Limited availability of specialized cardiac services (e.g. electrophysiologists)
 Limited to no availability of support services (e.g. in-hospital dieticians, cardiac rehabilitation)
Provider level
 Limited understanding of guideline-directed medical therapy of heart failure among community physicians and nurses
 Lack of time for comprehensive discharge education for patients and their families
 Discharge medications are prescribed for a limited supply (e.g. 1 month or less)
Patient and family level
 Limited understanding of heart failure and frustration with chronic disease process with repeat hospitalizations
 Longitudinal and recurrent costs of care (e.g. medications, hospitalizations, device therapy)
 Lost to follow-up after index hospitalization due to distance from specialty cardiac clinics
Table 3
Facilitators of heart failure care in Kerala, India.
Health system level
 Culture of quality improvement (data monitoring, analysis and designing interventions) catalyzed by national accreditation of hospitals
 Heart failure clinics with specialized nurses who can contact outpatients frequently to monitor symptoms and medication adherence
Provider level
 Experienced nursing staff
 Application of existing technology (e.g. “lung ultrasound”) to guide diagnosis
Patient and family level
 Educating patients and families regarding home monitoring of weight and adjustment of diuretics to prevent frequent readmissions
 Access to mobile phones allowing frequent contact with nurse and other nonphysician health-care providers
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care for heart failure and clinical practice
Patients with acute heart failure may be discharged from an
index hospitalization with guideline-directed medical therapy
prescribed by a cardiologist. However, respondents perceived that
community physicians may discontinue guideline-directedmedical
therapy (i.e. beta-blockers, angiotensin-converting enzyme in-
hibitors, angiotensin receptor antagonists, and mineralocorticoid
receptor antagonists) during follow-up in outpatient departments
because of concerns about side effects, including hypotension.
Cardiologists lack time for longitudinal follow-up for many patients
who may be experiencing progression of their heart failure.
Cardiologist respondents described the need for greater education
of health-care providers and patients on guideline-directed medial
therapy for acute heart failure.
“Many of the patients when [they] go out, they don't systematically
come back. They will naturally go to any other physician who tells
the patient that, ‘Look here, you are given these drugs for your
blood pressure.’ [The] [m]ost difficult situation is when you give
somebody with a blood pressure about [systolic blood pressure]
100 and 110 [mmHg] and ACE-inhibitor and beta blocker, and he
go(es) back to the physician, the first thing they do is cut. So that is
a major problem, we have to educate the patient. We have to tell
them, ‘Look here, these are your heart failure medication and don't
allow anybody to stop it unless you have compelling [contra]indi-
cation.’” (Cardiologist, private hospital)
Participants describe the limited availability of specialized car-
diac services such as electrophysiologists, which may further limit
optimal delivery of guideline-directed clinical care such as pace-
makers with cardiac resynchronization capability and implantable
cardioverter defibrillators.“We do not have [an] in-house electrophysiologist, but in case of a
need we have a visiting electrophysiologist who will go for a
difficult ICD [implantable cardioverter defibrillator] or CRT [cardiac
resynchronization therapy].” (Cardiologist, private hospital)
Furthermore, ancillary outpatient services, such as cardiac
rehabilitation, that improve the quality of life of patients with heart
failure are lacking in Kerala, which further limit guideline-directed
clinical care of patients with heart failure.
“The truth is that there is no definite cardiac rehabilitation centres,
not at all, that is the main problem. Acute [heart] failure man-
agement is not a problem.” (Cardiologist, government hospital)
3.2.3. Theme 3. National hospital accreditation has contributed to a
culture of systematically improving quality and safety of in-hospital
care
The process of obtaining and maintaining national quality
accreditation has systematically introduced principles of data
monitoring with expectations of activities to achieve high-
quality safe-care throughout the hospital and health system.
“We have been collecting data monthly. All the departments are
collecting the data … and they are denoting all the indicators and
we are collecting the monthly reports. If there is any drastic change,
for example sudden increase in medication errors, we have to
inquire why this has happened and [then] we are taking the
corrective and preventive actions.” (Quality administrator, private
hospital)
The process of obtaining and maintaining national quality
accreditation has also systematically introduced principles of
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quality and safety of care throughout the hospital.
“We have passive and active audits. There are direct observations
by the ward in charge who have been provided with the WHO
[World Health Organization] hand hygiene checklist. Second thing
is that we have surveillance group members assigned for each
department in that we have infection control, quality improvement
team, executives, microbiologist scoring the particular areas.
Sometimes we go for direct observations, sometimes we take cul-
tures, sometimes we have swabs directly and everybody is involved
in it. These tests are analyzed, sent to the committees and based on
the result, we give actions.” (Quality administrator, private
hospital)
The process of obtaining and maintaining national quality
accreditation has further contributed to the introduction of prin-
ciples of goal setting to improve quality targets, although somemay
not be realistic.
“In our hospital policy, we have our ISO [International Organization
for Standardization] accreditation so our goal is 0% readmission.
Once we receive the patients, we don't want them to come back
again to our hospital.” (Nurse, private hospital)
“If the ventilator is not working for an hour, then there is a set time
and within that time they have to clear that or else they have to
replace that ventilator. If that goal is not met, if that ventilator is
not replaced or that is not repaired within the time, then root cause
analysis is done and based on that corrective and preventive action
is taken.” (Quality administrator, private hospital)3.2.4. Theme 4. Kerala's health system has focused on improving the
quality and safety of acute coronary syndrome, but there has been
limited attention toward improving heart failure care despite the
increasing burden of disease
Participants described the changing disease patterns of the
intensive care unit with increasing heart failure admissions.
“Of the admissions coming to the ICU, ACS [acute coronary syn-
drome] [is] getting replaced by heart failure. At any point of time,
we often have more heart failure patients in ICU than ACS [acute
coronary syndrome].” (Cardiologist, private hospital)
Despite this increasing burden of heart failure, many health-care
providers continue to focus on delivering optimal acute coronary
syndrome care, given the system's current orientation. Most pa-
tients with acute coronary syndrome improve significantly after
percutaneous coronary intervention and have shorter hospitaliza-
tions with a lower risk for recurrent hospitalization than patients
with acute heart failure.
“Everybody is concerned about the ACS [acute coronary syndrome].
Once they are sure that it is not an ACS [acute coronary syndrome]
they don't take care. That's the problem. Actually,I can understand
… because heart failure is a headache. Because the patient will
have recurrent hospitalizations and need a lot of consult visitations
to take care of them. With acute ACS [acute coronary syndrome],
after 24 hours the patient is stable. The patient is happy, the family
is happy, the doctor is happy, the management is happy. But in
heart failure the doctor is struggling, the patient is struggling, the
family is unhappy, probably the management is [also] not so
happy.” (Cardiologist, private hospital)Multiple health-care providers described the clinical challenges
of taking care of patients with heart failure.
“[This is] perhaps [the] only generation of cardiology treating
more heart failure patients. The younger generation is only
interested in ACS [acute coronary syndrome]. That's why the
moment an ACS [acute coronary syndrome] case presents, [they]
come to the [cath] lab even before [they] see the patient. Whereas
in a heart failure [case], no one comes to attend the call … people
with heart failure do not [have a] future.” (Cardiologist, private
hospital)
3.2.5. Theme 5. The application of existing personnel and
technology can improve heart failure care
Many participants described nursing staff as key leverage points
to improve heart failure care, given their expertise and time
available to spend with patients compared with physicians,
although many respondents emphasized nurses' roles for acute,
rather than chronic management.
“Because in many cardiac centers, the nursing staff is excellent.
With many years of experience in cardiology, just by hearing the
history itself they will identify whether it is respiratory or cardiac.”
(Cardiologist, private hospital)
One facilitator of optimal acute heart failure care was use of
existing technology, such as lung ultrasound, to differentiate causes
of dyspnea upon patient presentation to the hospital at a lower cost
than other tests (e.g. B-type natriuretic peptide testing).
“When the patient reaches here, if we keep the ultrasound probe on
the lung, we can differentiate between images of the dry lung and
wet lung. Once we are familiar with that, we can identify [if] the
patient is having fluid collection in the lung” (Cardiologist, private
hospital)
Multiple participants described use of mobile technology,
including WhatsApp Messenger (WhatsApp Inc, Mountain View,
USA), as a method to facilitate communication for patient care.
Nurse-based longitudinal care of patients with heart failure has
been demonstrated to be effective at reducing the risk of rehospi-
talization andmortality, although data ensuring privacy of personal
health information and demonstrating effectiveness of this specific
messaging platform remain limited.14
“A dedicated nurse practitioner or one or two persons who is
specially trained for heart failure management can contact patients
through telephone or through WhatsApp. They can help to assess
the status at home and advise early admission or even early OPD
[outpatient department] visit. With [a] dedicated heart failure
clinic team, follow-ups can be by telephone to improve patient drug
compliance.” (Cardiologist, private hospital)
3.2.6. Theme 6. Longitudinal and recurrent costs remain a barrier
for optimal heart failure care
Many participants described the costs of medications as reasons
for suboptimal medication adherence.
“[In] the Indian context, they do not have enough money to
generate their medicine for 1 month, 2 months so sometimes they
stop diuretics, ACE-inhibitor. That is the main reason [for] drug
defaults.” (Nurse, private hospital)
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sacubitril/valsartan) further limit the prescribing patterns in private
and government hospitals, especially if the medication is not
offered in government hospital pharmacies.
“Most of the medications now for heart failure are very costly, very
costly. So we cannot go to the newer drug regime because then
compliance is less, so in the routine set up the economic aspects is
also [a] very important factor.” (Cardiologist, government hospital)
4. Discussion
We described the key themes regarding facilitators and barriers
of heart failure care in Kerala that emerged from in-depth in-
terviews with diverse health-care providers and quality adminis-
trators at the patient, family, provider, health system and health
policy level. Respondents identified in-hospital patient and family
education on heart failure as a key area of improvement, although
these are likely necessary but insufficient to improve the quality of
heart failure care. Participants described poor penetration of
guideline-directed clinical care for heart failure perhaps due to the
state health system's historical focus on acute coronary syndrome.
Application of existing technology and personnel could improve
heart failure care in Kerala; however, longitudinal and recurrent
costs remain barriers for optimal care. To our knowledge, this is the
first qualitative study of heart failure care in India and provides
valuable insights into Kerala's health system and policy response to
heart failure.
The World Health Organization (WHO) health system frame-
work characterizes six building blocks of a well-functioning health
system necessary to improve health outcomes.15 The first building
block is service delivery, which highlights access to quality health
services across the continuum of care. In the heart failure care
health system in Kerala, there is limited availability of support
services such as in-hospital registered dieticians and physical
therapy and no outpatient cardiac rehabilitation services (Theme
2). The lack of standardized cardiac rehabilitation services in Kerala
has been noted in prior studies in the region.16 Locally relevant
rehabilitation, such as yoga, might be a sustainable strategy for
improving heart failureerelated quality of life, based on prior yoga-
based cardiac rehabilitation for patients following acute coronary
syndrome.17 A key facilitator of heart failure care is heart failure
specialty clinics that include advanced practice heart failure nurses,
which currently exist at only a few specialized cardiac centers in
Kerala (Theme 5). Innovative models of same-day heart failure
access clinics for acute heart failure are being implemented in the
United States to mitigate the large and growing in-hospital acute
heart failure burden.18 Furthermore, qualitative research in the
United Kingdom illustrates the role specialist heart failure nurses
can have in facilitating coordination of care as a bridge between
primary and secondary care.19Wider adoption and implementation
of heart failure telemedicine service arrangements staffed by
nurses and other nonphysician health-care providers in Kerala is a
promising strategy to improve cardiovascular outcomes in the
state.
The second WHO health system building block is health work-
force. Participants identified a finite number of cardiovascular
specialists (i.e. advanced heart failure physicians, electrophysiolo-
gists) as a barrier to optimal heart failure care in Kerala (Theme 2).
However, training nurses as specialized advanced practice nurses to
be heart failure providers to triage patients with heart failure by
telephone and help staff outpatient heart failure clinics could be a
viable strategy to increase accessibility of specialized services. A2015 systematic review illustrated nurse-led titration of
angiotensin-converting enzyme inhibitors, angiotensin receptor
blockers, and beta-blockers reduced hospitalizations (relative risk
[RR] 0.80, 95% confidence interval [CI] 0.72 to 0.88, high-quality
evidence) and all-cause mortality (RR 0.66, 95% CI 0.48 to 0.92,
moderate-quality evidence) compared to usual care in patients
with heart failure with reduced ejection fraction.20
The third WHO health information system building block is
health information systems, including the implementation of heart
failure clinical guidelines across the continuum of care. Data from
India in the Trivandrum Heart Failure Registry illustrates even
lower adherence to guideline-directed medical therapy with only
25% of participants receiving optimal treatment at discharge.21
Furthermore, participants perceived that community physicians
discontinue guideline-directed medical therapy in the outpatient
setting, potentially exacerbating the current disparities between
guideline-directed clinical care and actual clinical practice (Theme
2), which might be related to fragmentation of care that is common
in Kerala. The 2017 American College of Cardiology Expert
Consensus Decision Pathway for Optimization of Heart Failure
Treatment highlights 7 evidence-based medications, 3 evidence-
based device strategies, and several recommended processes of
care for optimal care of patients with heart failure with reduced
ejection fraction.22 Hospital-level quality improvement in-
terventions have been designed to increase penetration of these
guideline recommendations; however, a 2019 systematic review of
randomized controlled trials of in-hospital heart failure quality
improvement interventions revealed no consistent effect on pro-
cess of care measures and clinical outcomes.23 A key facilitator of
the health information system in Kerala is a growing culture of data
collection, monitoring, and analysis introduced by national
accreditation (Theme 3) that may increase the readiness of hospi-
tals to benefit from future in-hospital quality improvement in-
terventions for patients with heart failure.13
The fourth WHO health system building block is access to
essential medicines. Many participants described the costs of
medications as reasons for reduced medication adherence
among patients (Theme 6). The Prospective Urban Rural Epidemi-
ology study (n ¼ 16,874 households) identified 59% of households
in India would find the combination of aspirin, beta-blockers,
angiotensin-converting enzyme inhibitors, and statins unafford-
able based on a 20% capacity to pay threshold.24 Although essential
medicines are free of direct costs in the public sector in Kerala,
participants noted that some heart failureespecific medications
were not always available in public sector pharmacies, leading to
higher out-of-pocket expenditures at private pharmacies. Monthly
medication prescriptions, rather than 3-month prescriptions, also
increase indirect costs (including related to travel and time off of
work) and the risk for nonadherence. The WHO Model List of
Essential Medicines is a tool used by the Government of India to
guide the National List of Essential Medicines, which is used for
drug procurement for the public health-care system.25 Ensuring
state and national essential medicine lists are updated in concor-
dance with national clinical practice guidelines may help increase
equitable and affordable access to essential heart failure medica-
tions in Kerala.26
The fifth WHO health system building block is health financing
to protect patients from financial catastrophe. Participants noted
longitudinal and recurrent costs remain a barrier for optimal heart
failure care in Kerala (Theme 6). These costs are related to direct
medication expenses and recurrent hospitalizations, indirect costs
associated with medicine-related travel and family care, and loss of
economic productivity due to poor health. Economic analysis using
data from the United States demonstrated 77% of lifetime costs of
heart failure are accrued during hospitalizations, and the overall
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failure was almost 20%.27,28 A 2011 cross-sectional study of the
microeconomic impact of cardiovascular disease hospitalization
revealed a lack of health insurance was associated with nearly
fourfold higher odds of catastrophic health spending in Trivan-
drum, India (odds ratio 3.93, 95% CI 2.23, 6.90).29 Potential solu-
tions to reduce the financial risk associated with heart failure in
Kerala include increased uptake of social health insurance pro-
grams and improved accessibility and affordability of heart failure
medications as part of a universal health coverage package. Cost-
effectiveness data demonstrate angiotensin receptor inhibitors
and beta-blockers for heart failure to be cost-saving (cost-effec-
tiveness ratio 219) in South Asia.14,30
The sixth WHO health system building block highlights the
importance of leadership and governance. The expanding role of
the National Accreditation Board for Hospitals and Healthcare
Providers (NABH) in hospitals in Kerala was identified by several
participants as a key facilitator of improving quality of heart failure
care (Theme 3).13 The introduction of data collection, monitoring,
and design of interventions in NABH-accredited hospitals has
demonstrated an increased readiness to change to improve quality
of care and safety. The need for the environment within which
health professionals function to be prepared to change was iden-
tified by the 2001 Institute of Medicine report as a critical step to
improve quality of care.31 The accreditation of NABH in
Kerala hospitals has increased the readiness of these hospitals for
heart failure quality improvement interventions by strengthening a
culture of quality and safety. Although in-hospital quality
improvement interventions for acute heart failure in high-income
countries do not show a consistent effect on process of care and
clinical outcomes, further research is needed in low- and middle-
income countries where the baseline quality of heart failure care
may be lower.23 Whether the process of accreditation itself im-
proves the quality and safety of care remains an important research
topic, particularly in rapidly changing health systems, including in
Kerala and India more broadly, where policies to promote improved
access can be complemented by policies to promote quality and
safety.
This qualitative study on heart failure care in Kerala has several
strengths. First, the qualitative methodology using semi-structured
interviews illustrated a variety of perspectives on heart failure care
at patient, family, provider, health system, and policy levels, which
have not been described before and may have been missed in a
quantitative study. Second, interviews were conducted using an
interview guide developed based on prior research in the region.9,16
Third, recorded interviews were transcribed by an independent
researcher, standardized coding was performed using qualitative
software for quality assurance, and the report adhered to standard
qualitative research reporting guidelines.
However, this qualitative study also has several limitations. First,
participants were selected from 8 hospital sites participating in a
heart failure quality improvement study, which introduces the risk
of selection and social desirability biases. However, we utilized a
purposive sampling frame and snowballing technique to recruit
additional informants to be inclusive in diverse perspectives on
heart failure care. Most participants were affiliated with private
hospitals, which represent a specific perspective, and we may have
missed some concepts as a result of the size of the sampling frame.
Second, semi-structured interviews were conducted in English.
Although English is spoken fluently by many providers in Kerala,
we may have missed nuances that would have emerged if Mala-
yalam were used. Third, patients with heart failure and their fam-
ilies were not included in the selected sample, which is a key area of
future research to understand their perspectives on heart failure
care in Kerala and strategies for improvement.5. Conclusions
Key themes emerged regarding heart failure care in Kerala,
including limited focus on heart failure in the region, poor pene-
tration of guideline-directed clinical care, recurrent costs of care,
and an increasing emphasis on health-care quality and safety. These
data can be useful to guide strategies for heart failure quality
improvement in Kerala and beyond.
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